Sign inJoin waitlistJoin the waitlist

Katharine J. Bar

Director, Virology Core · Penn Center for AIDS Research

Credentials: · · · · ·

History

Penn Medicine
Present

University of Alabama Medical Center
Virginia Commonwealth University School of Medicine
University of Iowa College of Medicine
2002

Research

Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection
The Journal of Experimental Medicine · 2009 · 649 citations
Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption
New England Journal of Medicine · 2016 · First of 38 authors · 421 citations
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19
New England Journal of Medicine · 2021 · 375 citations

George Shaw
30 papers
Barton Haynes
12 papers · 2 as a fellow
Pablo Tebas
11 papers
Ann Chahroudi
9 papers · 6 as a resident
Myron Cohen
9 papers
Sallie Permar
9 papers
GS
Guido Silvestri
7 papers
MC
Marina Caskey
7 papers
Dan Barouch
6 papers
Christopher Hurt
5 papers
David Margolis
5 papers
DW
David Weinreich
5 papers

Grants

Selective Inhibition of T Cell Trafficking to Brain in Acute SHIV.D Infected RM Will Prevent CNS Seeding, Persistence, and Neuropathogenesis
National Institute of Mental Health · R01
Contact PI · $1.2M · University of Pennsylvania
2026–2031
Therapeutic Vaccination to Boost Autologous Neutralizing Antibodies for ART Free HIV Control
National Institute of Allergy and Infectious Diseases · R37
Contact PI · $1.8M · University of Pennsylvania
2025–2030
Penn Center for AIDS Research
National Institute of Allergy and Infectious Diseases · P30
Project lead · $3.1M · University of Pennsylvania
1999–2029
Determining the Effects of Broadly Neutralizing Antibodies at Antiretroviral Therapy Initiation
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $3.4M · University of Pennsylvania
2023–2027

Clinical trials

COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2.
Principal investigator · Completed · Phase 1
University of Pennsylvania
2020–2021
COVID-19 Convalescent Plasma for Mechanically Ventilated Population
Principal investigator · Completed · Phase 1
University of Pennsylvania
2020–2021
Broadly Neutralizing Antibodies 3BNC117-LS & 10-1074-LS to Prevent Relapse During ATI
Study chair · Withdrawn · Phase 1
National Institute of Allergy and Infectious Diseases (NIAID)
2024
Analytical Treatment Interruption (ATI) to Assess the Immune System's Ability to Control HIV in Participants Who Became HIV-infected During the HVTN 704/HPTN 085 AMP Study
Study chair · Completed
HIV Vaccine Trials Network
2022–2024